Answers are grounded in this paper and cite their sources.
The aim of this review is to give an insight into the many potential applications of chitosan as a pharmaceutical drug carrier. The first part of this review concerns the principal uses of chitosan as an excipient in oral formulations (particularly as a direct tableting agent) and as a vehicle for parenteral drug delivery devices. The use of chitosan to manufacture sustained-release systems deliverable by other routes (nasal, ophthalmic, transdermal, and implantable devices) is discussed in the second part.
No takes yet. Share an insight, caveat, or question.
Felt et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: